Click on an item for a detailed description
04.06.19
- Made 1:10 dilutions of all primers
| Primers | Cloning of Droplet forming proteins | TM °C | Ta °C | ||
| Name | Tube name | Sequence (overlap/spacer/ANNEAL) | Use | ||
| pBAD33_fwd | pBAD33_sfGFP_gibson_f | gctctacaaaTAAATCGATCGCGTTAGG | Gibson primer to join sfGFP and the start of the pBAD33 Backbone ( | 58.5 | 56.1 |
| pBAD33_rev | pBAD_FUS_gibson_rev | tagacgccatGCTAGCATTATACCTAGG | Gibson primer to join FUS and the end of pBAD33 Backbone | 55.1 | 56.1 |
| FUS_fwd | FUS_pBAD33_gibson_fw | taatgctagcATGGCGTCTAATGACTACACTCAGC | Gibson primer to join FUS and the end of pBAD33 Backbone (reverse) | 68.3 | 69.3 |
| FUS_rev | FUS_sfGFP_gibson_rev | cggatcctccGTATGGGCGCTCGCGACG | Gibson primer to join FUS and the sfGFP with linker(reverse) | 72.4 | 69.3 |
| linker_spGFP_fwd | gsGFP_pBAD33_gibson_f | gcgcccatacGGAGGATCCGGAGGATCC | Joins the start of sfGFP to the end of fus | 67.0 | 65.6 |
| linker_spGFP_rev | spGFP_pBAD33_gibson_r | gatcgatttaTTTGTAGAGCTCATCCATGCC | Gibson primer to join sfGFP and the start of the pBAD33 Backbone | 64.6 | 65.6 |
| SPD5 | |||||
| pBAD33_fwd | pBAD_SPD5_fwd | gctctacaaaTAAATCGATCGCGTTAGG | Gibson primer to join stGFP and the start of the pBAD33 Backbone | 58.5 | 56.1 |
| pBAD33_rev | pBAD33_SPD5_gibson_rev | tatcttccatGCTAGCATTATACCTAGG | Gibson primer to join stGFP and the start of the pBAD33 Backbone (reverse) | 55.1 | 56.1 |
| SPD5_1_fwd | SPD5_pBAD33_gibson_fwd | taatgctagcATGGAAGATAACTCTGTCCTTAATGAAG | Gibson primer to join SPD5_1 at the end of pBAD33 | 63.5 | 64.5 |
| SPD5_1_rev | SPD5_1_gibson_rev | gtgcaatagtGAAACGACGCGACGCTTC | Gibson primer to join SPD5_1 at the end of pBAD33 (reverse) | 67.2 | 64.5 |
| SPD5_2_fwd | SPD5_2_gibson_fw | gcgtcgtttcACTATTGCACCGGATGCTG | Gibson primer to join SPD5_2 at the end of SPD5_1 | 65.2 | 62.6 |
| SPD5_2_rev | SPD5_2_sfGFP_gibson_rev | cggatcctccCTTCTTGCGAATTTCCTTTACG | Gibson primer to join SPD5_2 at the end of SPD5_1 (reverse) | 61.6 | 62.6 |
| linker_spGFP_fwd | sfGFP_SPD5_2_gibson_fw | tcgcaagaagGGAGGATCCGGAGGATCC | Forward primer for sfGFP (at the end of SPD5) | 67.0 | 65.6 |
| linker_spGFP_rev | sfGFP_pBAD33_gibson_rev | gatcgatttaTTTGTAGAGCTCATCCATGCC | Reverse primer GFP at the start of pBAD | 64.6 | 65.6 |
| mCherry | |||||
| pBAD33_fwd | PBAD33_mCherry_gibson_fwd | cgagctgtacTAAATCGATCGCGTTAGG | Gibson primer to join mCHERRY and the start of the PBAD33 Backbone | 58.5 | 56.1 |
| pBAD33_rev | pBAD_EWSR1_gibson_rev | ttgaggccatGCTAGCATTATACCTAGG | Gibson primer to join mCHERRY and the start of the PBAD33 Backbone (reverse) | 55.1 | 56.1 |
| EWSR1_fwd | EWSR1_pBAD33_gibson_fwd | taatgctagcATGGCCTCAACTGACTACTC | Gibson primer to join EWSR1 and the end of the PBAD33 Backbone | 63.7 | 64.7 |
| EWSR1_rev | EWSR1_mCherry_gibson_rev | ccttgctcacggatcctccggatcctccATAGGGACGATCACGGCG | Gibson primer to join EWSR1 and the end of the PBAD33 Backbone (reverse) | 67.1 | 64.7 |
| GS_mCherry_fwd | mCherry_EWSR1_gibson_fwd | tcgtccctatggaggatccggaggatccGTGAGCAAGGGCGAGGAG | Gibson primer to join mCHERRY and the end of the EWSR1 | 68.8 | 66.9 |
| GS_mCherry_rev | mCherry_pBAD33_gibson_rev | gatcgatttaGTACAGCTCGTCCATGCC | Gibson primer to join mCHERRY and the end of the EWSR1 (reverse) | 65.9 | 66.9 |
| NiCD | |||||
| pBAD33_fwd | pBAD33_sfGFP_gibson_fwd | tgagctctacaaaTAAATCGATCGCGTTAGGC | Gibson primer to join sfGFP and the start of the PBAD33 Backbone | 57.1 | 60.4 |
| pBAD33_rev | pBAD33_NICD_gibson_rev | tgacgcattcatGCTAGCATTATACCTAGGACTG | Gibson primer to join sfGFP and the start of the PBAD33 Backbone (reverse) | 56.9 | 60.4 |
| NICD_fwd | NICD_pBAD33_gibson_fwd | gtataatgctagcATGAATGCGTCATGTGTAGGGG | Gibson primer to join NICD at the end of pBAD33 | 62.5 | 65.6 |
| NICD_rev | NICD_sfGFP_rev | ctcctttgctcatggatcctccggatcctccGACCAGATGGCCGCGCAG | Gibson primer to join NICD at the end of pBAD33 (reverse) | 65.7 | 65.6 |
| sfGFP_fwd | sfGFP_NICD_fwd | ggccatctggtcggaggatccggaggatccATGAGCAAAGGAGAAGAACTTTTC | Gibson primer to join sfGFP at the end of NCID | 59.1 | 60.8 |
| sfGFP_rev | sfGFP_pBAD33_rev | gcgatcgatttaTTTGTAGAGCTCATCCATGC | Gibson primer to join sfGFP at the end of NCID (reverse) | 57.3 |
60.8 |
Ordered gBlocks sequences:
EWSR1 (Ewing Sarcoma Breakpoint Region 1):
atggcctcaactgactactccacttactcgcaggcagcagcacagcaaggctacagcgcttatacagcccagccaacgcaaggatatgcccaaacaacgcaggcatacggtcagcagtcttacggcacttacggccagccaactgatgtctcttacactcaagctcagaccacagcgacttatggccagaccgcatatgccacctcttacggtcagcccccgaccgtggaaggaacgtcgactggctatacaactccaaccgctcctcaagcatacagccagccagtccaaggatatggaaccggtgcatacgatacaacaactgccacagtgacgactacacaggcttcttatgcagctcagagtgcatatgggactcaaccagcatacccggcatacggccagcagccagctgcaacagctccaacgcgtcctcaggatggcaacaagccaacagagacctcgcaaccccagtccagtacaggtggctacaatcagccctccttggggtatgggcagagtaactactcgtacccccaagtccccggttcttaccctatgcagcctgtcacggcgcccccgagctatccacctacctcctatagcagtacgcagcccacgtcatatgatcagtcctcatattcccagcaaaacacatatgggcaacctagcagttatggccagcagtcttcgtacgggcagcagtcatcgtatggacagcaacctccgacatcatatccaccacagaccggatcgtactctcaggcaccatcacaatattctcagcaatcatcgtcatacggtcagcagtcttcttttcgtcaggatcatccttcttcgatgggtgtatatggccaagaatcggggggattctctggaccgggtgagaaccgtagtatgtcaggcccagacaaccgtggccgtggtcgtggcggtttcgatcgtggtggcatgtcgcgcggtgggcgtggtgggggccgcgggggtatgggggcaggggagcgtggtgggtttaacaaaccaggtggaccgatggatgagggcccagatcttgacttgggtccaccagtcgatccggatgaggattcagacaatagtgcaatttacgtgcaggggttaaatgactccgtgacgctggatgatctggccgatttcttcaaacaatgcggcgtagtaaaaatgaataaacgcacaggtcaacccatgattcatatctacttggacaaagagactggcaaaccaaaaggagacgctacggtatcatatgaggaccctccaacagctaaagccgctgttgagtggtttgatggaaaagacttccagggaagcaaattaaaggtatcattagcgcgtaaaaaaccacctatgaactcaatgcgcggcggactgccgccccgcgaaggtcgtggtatgccaccgccacttcgtggaggacctggaggtccaggaggtccaggtggtcctatgggacgaatgggaggtcgtggcggcgaccgcgggggttttcctccgcgcgggccccgtggtagtcgtggtaacccttcagggggcggcaacgtgcaacatcgcgcaggcgattggcagtgtccaaacccgggttgcggtaatcagaacttcgcgtggcgtacagaatgtaatcagtgcaaagcgccaaaaccagaaggttttcttccacccccgtttccacctccaggcggagaccgtggccgtggagggccgggtggtatgcgcggcggacgcggaggtcttatggatcgcggtggtccgggcgggatgtttcgtgggggtcgcggcggggatcgtggaggtttccgcggaggtcgcggaatggatcgtggcggattcggaggaggacgtcgtggtggtccaggggggcctcctggtcctctgatggagcagatgggagggcgccgcggtggtcgtggcgggccaggcaagatggataaaggtgagcaccgtcaagagcgccgtgatcgtccctatggaggatccggaggatcc
FUS:
atggcgtctaatgactacactcagcaagctacccaatcttatggggcatatccgacccaacctggccaaggctattcccaacagtcatcacaaccttacgggcaacaaagttattccggttacagccagtcaacagatacttctggatatggtcagtcttcctattcgtcatacggtcagagtcagaatacgggttacgggacacaatcaaccccgcaggggtacggttccaccggcggctatggctccagccaatcgagtcaatcaagttatgggcaacaatcttcttatcccggctatggccaacagccggccccgagctccacatccggttcatatggttcttcaagccaatcaagctcgtatggtcagccgcagtcaggaagctattcacagcagccgtcctacgggggacaacaacagagttacggacagcaacagagttataacccaccgcaaggctacgggcagcagaatcagtacaattcctcttcaggtggtggtggtggcggtggtggtggagggaattacgggcaagatcaatctagtatgtcttcaggagggggcagcggtgggggatacggcaatcaagatcaaagtggtggaggtggatctggaggttatggacagcaggatcgtggaggtcgcggccgcggcggctctggtggtggtgggggaggaggaggtggtgggtacaatcgtagctccggaggatacgagccacgtgggcgtgggggcggtcgcggtgggcgcggtgggatgggtggctctgaccgcggcggttttaataagttcggtggtccccgtgatcagggttcacgccacgatagtgagcaagacaacagtgataacaatacgatcttcgttcaaggtcttggagagaacgttacaattgaatcggtagcagactatttcaaacagattggtattattaaaaccaacaagaagacaggccaaccgatgattaacttgtatactgaccgtgaaaccggtaaattaaaaggggaggctaccgtatcctttgacgaccctccaagcgcaaaagctgccattgactggtttgacggtaaagaattttctggcaacccgattaaggtgtccttcgcaacacgccgtgcggacttcaaccgtggcggggggaacggacgtggggggcgcggccgcggaggtccaatggggcgcggagggtatggaggaggaggcagtggtgggggtggacgtggtggtttccccagcggcggcggaggaggaggcggtcagcaacgtgccggtgattggaagtgtcctaatccaacctgcgaaaatatgaacttctcttggcgcaatgagtgtaaccagtgcaaggcaccgaaacctgatggcccaggtggcgggccagggggaagccacatgggcggaaattacggtgatgatcgtcgcggcggccgtgggggatacgaccgtggtggctatcgtggccgtggtggagatcgcggtggcttccgtggtgggcgcggaggaggtgaccgcggagggtttgggccggggaagatggacagccgtggcgaacaccgtcaagatcgtcgcgagcgcccatac
NICD (Nephrin Intracellular Domain)
atgaatgcgtcatgtgtagggggtgtgatttggcagcgccgtattcgccgtctggccgaaggaatttcggaaaaaacagaagccggttccgaggaggaccgtgttcgtaatgaatacgaagaatcgcaatggaccggtgagcgcgatacgcaatctagtaccgtatccacgacagaagcagagccttattatcgcagtatccgcgatgaaagtccacagcttcctcctacacaggaagaggtttcctatagccgtggcgaaactggggaggatgaggatatggcagagccgggtcacttgtacgatgaggtagagcgcacttacccacctagcggcgcatggggtcccctgtacgatgaagtccagatggggccctgggatctgcattggcctgaggacacttatcaagaccctcgcggaatctatgaccaggttgcgggcgatcttgacactctggagcctgattcgctgccgtttgagctgcgcggccatctggtcggaggatccggaggatcc
SPD5:
atggaagataactctgtccttaatgaagatagtaaccttgagcacgtcgaaggtcagcctcgtcgtagtatgtctcaaccagtactgaatgtcgaaggtgacaagcgcacttctagcacaagtgcaacacagcagcaagttctttccggtgcgttctcttccgctgatgtccgctcaattccgatcatccaaacgtgggaagaaaacaaggctttgaaaacgaagatcacaattcttcgcggtgagctgcaaatgtaccaacgccgctatagtgaagccaaggaggcaagccagaagcgtgtcaaagaggttatggatgactatgtggacttaaaattaggtcaagaaaatgtacaagagaagatggaacaatacaagttaatggaagaagacttattggcgatgcaatcccgtattgaaacgtcggaagataatttcgcgcgtcagatgaaggaatttgaagcccaaaaacatgccatggaagaacgtattaaggagttggaactttccgccaccgatgctaacaacactacagtaggtagttttcgcgggacgcttgacgatatcttgaagaagaacgaccccgactttaccttaacctccggatatgaagaacgtaagatcaatgacttagaagccaagttacttagcgaaatcgataaggtggcagaactggaggaccacatccagcagttgcgccaagaacttgatgatcaaagtgcgcgcttagctgattcagagaacgtgcgcgctcagctggaagcggctaccggacaaggaatcttgggagctgctgggaatgcaatggtcccaaattcaacgttcatgatcgggaacgggcgcgaatctcaaacgcgcgatcagttgaattacatcgatgatttggaaactaagcttgcagatgctaagaaggaaaatgacaaggcccgtcaggccttagtggagtatatgaataaatgttcaaagcttgaacacgagatccgcactatggtaaagaatagtacgtttgacagctcatcaatgttattgggcggtcagaccagcgacgaattaaagattcagattggaaaggtaaatggagaattaaacgtacttcgcgccgagaatcgcgagcttcgcattcgctgcgatcaacttactggaggggacggtaacctttctatcagtcttggccaaagtcgtctgatggctgggattgctacaaacgatgtggatagtattggccaagggaatgaaaccggcgggacgagtatgcgtatcttgccacgcgagtcgcagttagacgacttggaagaaagtaagttgcctttaatggatactagtagtgcggtccgcaaccaacaacagttcgccagcatgtgggaagattttgagtccgtgaaagactcactgcaaaacaaccataacgacacccttgagggctcgtttaatagtagtatgccacccccagggcgcgatgccacccagtcatttctttctcagaaatcttttaagaatagcccaattgtgatgcaaaagccgaagagcttacacttgcaccttaagtcacatcagagcgagggggcgggggagcagattcagaataatagtttctctactaagacggcgagtccgcatgtctcccagagccatatcccaatccttcacgacatgcaacaaattctggactcatcggcgatgtttttagaaggtcaacacgacgttgcagttaatgtggaacaaatgcaagaaaagatgtctcagattcgcgaggcccttgcgcgcttgttcgagcgcctgaaatcgagtgccgcattattcgaggaaattctggaacgcatgggcagttcagatccaaacgccgataagattaaaaaaatgaagttagctttcgagacgtcgatcaacgataaattaaacgtgtctgctattcttgaggcggccgagaaggatttacataacatgagcttaaacttttcaatcttagagaagagtatcgtaagccaagctgccgaagcgtcgcgtcgtttcactattgcaccggatgctgaagacgttgcatccagttctcttcttaatgcgagttactcgccgttgtttaagtttacttccaactccgatatcgttgaaaagcttcagaatgaagtctcagaacttaaaaacgagttagagatggcacgcacacgtgatatgcgcagcccccttaacggatcttccgggcgtcttagtgacgtgcagatcaacacaaaccgcatgtttgaagatcttgaggtatccgaggcaacgcttcagaaggccaaggaagagaactccactctgaaatcacagtttgctgagcttgaggcgaacttgcaccaggtgaattctaagttaggggaggtgcgctgcgagttaaatgaggccttggcccgtgtggacggagagcaagagactcgtgtaaaggctgagaacgcgttagaagaagctcgccaattgatttcttcccttaaacatgaggaaaatgagttaaagaagactattactgatatggggatgcgtcttaatgaagcaaaaaagtccgacgagttcctgaaatccgagctttctaccgctttggaggaggagaaaaaatcccaaaatttagcagacgagttgtcagaggaacttaacggttggcgtatgcgtacgaaggaagcggagaataaagtagaacatgcgtcctcggagaagagcgagatgctggaacgtatcgtgcatcttgaaacggaaatggagaagctgtcaacctctgaaattgcagcggactattgttctacgaagatgactgagcgcaaaaaggaaattgagttggcaaagtaccgcgaagattttgagaacgccgctattgtgggcctggaacgtatttcaaaagaaatctctgagttaactaagaagacactgaaggcaaagatcattccatcgaacatctcaagcatccagcttgtctgcgatgagctttgccgtcgtctgtcacgcgagcgcgagcaacaacacgaatacgccaaggttatgcgtgacgtcaatgagaagatcgaaaaattgcaattagaaaaagatgcgttggaacacgagttgaaaatgatgtcaagtaataatgaaaacgtgcctcctgtcgggacttcagttagcggcatgccgacaaagacgagtaatcaaaaatgcgcgcaaccacactacacgtcaccgactcgccaacttctgcatgagtcaaccatggcggtcgacgcgattgtccagaaattgaagaaaacacacaacatgagcgggatgggaccagagttgaaagaaacaattggtaacgtgatcaacgaatcacgtgtcttgcgcgactttcttcatcaaaagcttattttgtttaagggcattgatatgtctaattggaagaatgaaacggttgatcagctgatcaccgatttaggccagctgcaccaggacaatctgatgttggaagaacagatcaagaaatataaaaaggaacttaagcttaccaaaagtgcgatccctactcttggagtggaattccaggatcgtattaagaccgaaattgggaaaattgcgacggacatgggcggagccgtaaaggaaattcgcaagaag
| Created Plasmids in first cloning phase | |||||
| Backbone | Insert | Insert | Promoter | Resistance | |
| P1 | pBAD33 | EWSR1 | mCherry | J23119 | Chloramphenicol |
| P2 | pBAD33 | FUS | sfGFP | J23119 | Chloramphenicol |
| P3 | pBAD33 | SPD5 | sfGFP | J23119 | Chloramphenicol |
| P4 | pBAD33 | NICD | sfGFP | J23119 | Chloramphenicol |
Labbook 05.06.2019
Performed amplifications of the Backbones (all Plasmids will be constructed with a pBAD33 backbone), sfGFP and mCherry genes from plasmids.
Following PCR constructs were made:
For FUS: (A) pBAD amplification with Primers 1&2* (not successful)
(B) sfGFP amplification with Primers 5&6*
For SPD5: (D) pBAD amplification with Primers 7&8* (not successful)
(E) sfGFP amplification with Primers 13&14* (not successful)
For EWSR1: (H) pBAD amplification with Primers 15&16*
(I) mCherry amplification with primers 19&20*
*For sequences of primers and roteins see Protocol from Day 04.06.2019
PCR tubes contained: 2,5 μl of each primer (diluted 1:10)
1 μl DNA
19 μl H2O
25 μl Phusion Flash Master Mix (Thermo Fisher Scientific)
Fragments B, H and I were successfully amplified, identified via Gel electrophoresis and purified.
PCR for DNA fragments A, D and E were set up again. To troubleshoot the PCRS, higher Backbone concentrations of about 2 ng were used. Also for fragment E, 3% of DMSO were added to the PCR mix. Also, two different Polymerases were used (Q5 and Phusion Flash).
Furthermore, constructs amplifying pBAD33 (A and D) were incubated overnight with 0,5μl DPN1 enzyme at 37°C to digest methylated bacterial DNA.
All amplifications and purifications were successful. Unfortunately, the PCR image has been lost because of technical issues with the GelViewer.
NICD (Nephrin Intracellular Domain) was amplified, as well as sfGFP and pBAD33 with respective overlaps.
Following PCRS were set up:
(J) pBAD amplification with primers 1&22*
(K) sfGFP amplification with primers 25&6*
(L) NICD amplification with primers 23&24*
*For all sequences see table in protocol from 04.06.2019
All amplifications were successful, see picture below.
Afterwards, gibson cloning was set up. Considering sizes, amound of insert for 50 ng backbone was calculated.
NICD: 17.6 ng
sfGFP: 24 ng
The DNA was diluted with water until reaching 5 microliters of volume and mixed in a 1:1 ratio with a HiFi ligase/exoniuclease mastermix and incubated at 50°C for 15 minutes. Afterwards competent Top10 E. Coli were transformed with 2 microlitres of Gibson Assembly Mix and incubated overnight.
After transformation of NICD was ineffective, proportions were calculated again and ligation was repeated. Incubation overnight follows.
Furthermore, gBlocks for EWSR1, FUS, SPD5_1 and SPD5_2 were amplified to create overlaps with following